Table 3.
Toxicity profile after treatment
| Complications | 0 | I | II | III | IV | III + IV, % (n) |
|---|---|---|---|---|---|---|
| %(n) | % (n) | % (n) | % (n) | % (n) | ||
| Hematological toxicities | ||||||
| Anemia | 32 (6) | 26 (5) | 32 (6) | 11 (2) | 0 | 11 (2) |
| Leukopenia | 21 (4) | 32 (6) | 26 (5) | 16 (3) | 5 (1) | 21 (4) |
| Neutropenia | 16 (3) | 32 (6) | 26 (5) | 21 (4) | 5 (1) | 26 (5) |
| Thrombocytopenia | 26 (5) | 42 (8) | 21 (4) | 5 (1) | 5 (1) | 11 (2) |
| Non-hematological toxicities | ||||||
| Nausea | 37 (7) | 37 (7) | 16 (3) | 11 (2) | 0 | 11 (2) |
| Vomiting | 47 (9) | 32 (6) | 11 (2) | 11 (2) | 0 | 11 (2) |
| Anorexia | 53 (10) | 26 (5) | 11 (2) | 5 (1) | 5 (1) | 11 (2) |
| Hemorrhage | 90 (17) | 5 (1) | 5 (1) | 0 | 0 | 0 |
| Fatigue | 37 (7) | 32 (6) | 26 (5) | 5 (1) | 0 | 5 (1) |
| ALT/AST | 89 (15) | 16 (3) | 5 (1) | 0 | 0 | 0 |
| Arrhythmia | 63 (12) | 37 (7) | 0 | 0 | 0 | 0 |
| Esophagitis | 26 (5) | 37 (7) | 16 (4) | 11 (2) | 5 (1) | 16 (3) |
| Pneumonitis | 21 (4) | 26 (5) | 26 (5) | 26 (5) | 0 | 26 (5) |